ID

42142

Descrizione

A Study of ARQ 197 in Combination With Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT01251796

collegamento

https://clinicaltrials.gov/show/NCT01251796

Keywords

  1. 29/05/16 29/05/16 -
  2. 13/04/21 13/04/21 - Dr. rer. medic Philipp Neuhaus
Caricato su

13 aprile 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
voluntary written informed consent for study participation must be obtained
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
Descrizione

non-small-cell lung cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0007131
history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
Descrizione

chemotherapy regimen

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1443775
ecog ps of 0 or 1
Descrizione

ecog

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of ≥3 months
Descrizione

life expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
poor metabolizers as defined by cyp2c19 genotype
Descrizione

CYP2 gene

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1332828
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
Descrizione

egfr-tki

Tipo di dati

boolean

surgery for cancer within 28 days prior to arq 197 dose
Descrizione

cancer surgery

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0920424
active double cancer
Descrizione

Multiple malignancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0346429
known symptomatic brain metastases
Descrizione

brain metastases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
Descrizione

intercurrent illness

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3640977
pregnant or lactating
Descrizione

pregnant or lactating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subjects who wish to have a child and who would not agree to use contraceptive measures
Descrizione

contraceptive measures

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700589

Similar models

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
voluntary written informed consent for study participation must be obtained
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
chemotherapy regimen
Item
history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
boolean
C0392920 (UMLS CUI [1,1])
C1443775 (UMLS CUI [1,2])
ecog
Item
ecog ps of 0 or 1
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of ≥3 months
boolean
C0023671 (UMLS CUI [1])
CYP2 gene
Item
poor metabolizers as defined by cyp2c19 genotype
boolean
C1332828 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
egfr-tki
Item
anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
boolean
cancer surgery
Item
surgery for cancer within 28 days prior to arq 197 dose
boolean
C0920424 (UMLS CUI [1])
Multiple malignancy
Item
active double cancer
boolean
C0346429 (UMLS CUI [1])
brain metastases
Item
known symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
intercurrent illness
Item
an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
boolean
C3640977 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
contraceptive measures
Item
subjects who wish to have a child and who would not agree to use contraceptive measures
boolean
C0700589 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial